| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -32.72M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ABOS returned +102.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +46.9% |
| 1 year | +102.5% |
| 5 years | -82.7% |
| All-time high | $17.92 (Aug 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ABOS would be worth today ›No. Acumen Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Acumen Pharmaceuticals, Inc. stock trades on NASDAQ under the ticker symbol ABOS.
Acumen Pharmaceuticals, Inc. is part of the Healthcare sector.
Acumen Pharmaceuticals, Inc. has a market cap of 224.11M USD, based on the latest quote.
Acumen Pharmaceuticals, Inc. is scheduled to report earnings on Nov 11, 2026.
